Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario R Romano

Showing results (71-80 of 279) with videos related to

Pageof 28
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 10, 2007
Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaksMichele Rinaldi, Roberto Dell'Omo, Mario R Romano, et al.
European Journal of Ophthalmology|February 27, 2024
Small-Incision new generation implantable miniature telescope surgical technique and patient outcomesMario R Romano, Tania Sorrentino, Davide Allegrini, et al.
Frontiers in Pharmacology|December 10, 2025
Safety profile of lutein-based blue dyes and surgical lightsMario R Romano, Federica Conti, Francesca Lazzara, et al.
Translational Vision Science & Technology|March 2, 2016
The Effect of Temperature Changes in Vitreoretinal SurgeryMario R Romano, Vito Romano, Alessandro Mauro, et al.
Survey of Ophthalmology|February 1, 2022
Management of refractory and recurrent macular holes: A comprehensive reviewMario R Romano, Tommaso Rossi, Alfredo Borgia, et al.
Mediators of Inflammation|February 1, 2013
Vitreous mediators in retinal hypoxic diseasesRoberto dell'Omo, Francesco Semeraro, Giulio Bamonte, et al.
International Ophthalmology|September 18, 2013
Myopia onset and progression: can it be prevented?Andrea Russo, Francesco Semeraro, Mario R Romano, et al.
Expert Opinion on Drug Safety|May 10, 2014
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overviewFrancesco Semeraro, Francesco Morescalchi, Sarah Duse, et al.
Mediators of Inflammation|November 8, 2013
Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloidFrancesco Morescalchi, Sarah Duse, Elena Gambicorti, et al.
Current Eye Research|June 24, 2008
Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprostCiro Costagliola, Claudio Campa, Paolo Perri, et al.
Pageof 28

Showing results (71-80 of 279) with videos related to

Sort By:
Pageof 28
Archives of Ophthalmology (Chicago, Ill. : 1960)|October 10, 2007
Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaksMichele Rinaldi, Roberto Dell'Omo, Mario R Romano, et al.
European Journal of Ophthalmology|February 27, 2024
Small-Incision new generation implantable miniature telescope surgical technique and patient outcomesMario R Romano, Tania Sorrentino, Davide Allegrini, et al.
Frontiers in Pharmacology|December 10, 2025
Safety profile of lutein-based blue dyes and surgical lightsMario R Romano, Federica Conti, Francesca Lazzara, et al.
Translational Vision Science & Technology|March 2, 2016
The Effect of Temperature Changes in Vitreoretinal SurgeryMario R Romano, Vito Romano, Alessandro Mauro, et al.
Survey of Ophthalmology|February 1, 2022
Management of refractory and recurrent macular holes: A comprehensive reviewMario R Romano, Tommaso Rossi, Alfredo Borgia, et al.
Mediators of Inflammation|February 1, 2013
Vitreous mediators in retinal hypoxic diseasesRoberto dell'Omo, Francesco Semeraro, Giulio Bamonte, et al.
International Ophthalmology|September 18, 2013
Myopia onset and progression: can it be prevented?Andrea Russo, Francesco Semeraro, Mario R Romano, et al.
Expert Opinion on Drug Safety|May 10, 2014
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overviewFrancesco Semeraro, Francesco Morescalchi, Sarah Duse, et al.
Mediators of Inflammation|November 8, 2013
Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloidFrancesco Morescalchi, Sarah Duse, Elena Gambicorti, et al.
Current Eye Research|June 24, 2008
Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprostCiro Costagliola, Claudio Campa, Paolo Perri, et al.
Pageof 28